{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:32:57Z","timestamp":1793244777722,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":1972,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.fertnstert.2016.09.027","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T13:47:20Z","timestamp":1477403240000},"page":"43-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["Combined hormonal contraception and the risk of venous thromboembolism: a guideline"],"prefix":"10.1016","volume":"107","author":[{"given":"Samantha","family":"Pfeifer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Butts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Dumesic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Fossum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisa","family":"Gracia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"La Barbera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Mersereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Odem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Penzias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Pisarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rebar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Reindollar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Sandlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Vernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Widra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2016.09.027_bib1","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/AOG.0b013e318277c93b","article-title":"ACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/13625187.11661693.1996","article-title":"Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens","volume":"1","author":"van Lunsen","year":"1996","journal-title":"Euro J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0010-7824(97)00119-4","article-title":"First-time use of newer oral contraceptives and the risk of venous thromboembolism","volume":"56","author":"Suissa","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/humupd\/5.6.707","article-title":"The Transnational Study on Oral Contraceptives and the Health of Young Women. Methods, results, new analyses and the healthy user effect","volume":"5","author":"Lewis","year":"1999","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib5","first-page":"1034","article-title":"Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins","volume":"81","author":"Speroff","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0010-7824(02)00473-0","article-title":"Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties","volume":"67","author":"Hammond","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0010-7824(94)00015-O","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models","volume":"51","author":"Muhn","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib8","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/ije\/19.4.931","article-title":"Oral contraceptive oestrogen and progestin potencies and the incidence of deep venous thromboembolism","volume":"19","author":"Gerstman","year":"1990","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib9","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0010-7824(96)00112-6","article-title":"The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"54","author":"Lewis","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib11","first-page":"1657","article-title":"The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study","volume":"48","author":"Hannaford","year":"1998","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib12","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib13","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib14","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.beem.2012.11.002","article-title":"Hormonal contraceptives and venous thromboembolism: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib16","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib17","article-title":"Combined oral contraceptives: venous thrombosis","volume":"CD010813","author":"de Bastos","year":"2014","journal-title":"The Cochrane database of systematic reviews"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib18","first-page":"331","article-title":"Evaluation of risk factors associated with vascular thrombosis in women on oral contraceptives. Possible role of anti-sex steroid hormone antibodies","volume":"11","author":"Beaumont","year":"1983","journal-title":"Artery"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0010-7824(85)90072-1","article-title":"Deep vein thrombosis and the oestrogen content in oral contraceptives. An epidemiological analysis","volume":"31","author":"Kierkegaard","year":"1985","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib20","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/eurheartj\/12.11.1219","article-title":"Oral contraceptives, sex steroid-induced antibodies and vascular thrombosis: results from 1318 cases","volume":"12","author":"Beaumont","year":"1991","journal-title":"Eur Heart J"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"312","author":"Spitzer","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib22","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(96)07496-X","article-title":"Population-based study of risk of venous thromboembolism associated with various oral contraceptives","volume":"349","author":"Farmer","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0010-7824(98)00033-X","article-title":"Oral contraceptives and venous thromboembolism. A case-control study","volume":"57","author":"Lidegaard","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib25","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1016\/S0002-9378(99)70696-4","article-title":"Smoking and use of oral contraceptives: impact on thrombotic diseases","volume":"180","author":"Lidegaard","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2125.2000.00198.x","article-title":"A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives","volume":"49","author":"Farmer","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"3rd. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-0037-1614213","article-title":"Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism","volume":"79","author":"Andersen","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib29","first-page":"393","article-title":"Oral contraceptives, venous thrombosis, and varicose veins. Royal College of General Practitioners' Oral Contraception Study","volume":"28","year":"1978","journal-title":"J R Coll Gen Pract"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib30","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/jth.12224","article-title":"Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?","volume":"11","author":"Bird","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib31","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib32","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib33","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1053\/ob.1998.v179.a92634","article-title":"Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany","volume":"179","author":"Farmer","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib34","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/humupd\/5.6.688","article-title":"Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK Mediplus database","volume":"5","author":"Farmer","year":"1999","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/bmj.321.7259.477","article-title":"Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database","volume":"321","author":"Farmer","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0010-7824(98)00002-X","article-title":"The risks of venous thromboembolic disease among German women using oral contraceptives: a database study","volume":"57","author":"Farmer","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib38","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1053\/ob.1998.v179.a91674","article-title":"Thrombotic diseases in young women and the influence of oral contraceptives","volume":"179","author":"Lidegaard","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib39","doi-asserted-by":"crossref","first-page":"21S","DOI":"10.1016\/S0010-7824(00)00147-5","article-title":"Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference?","volume":"62","author":"Lawrenson","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib40","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/humrep\/14.6.1493","article-title":"The differential risk of oral contraceptives: the impact of full exposure history","volume":"14","author":"Lewis","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0010-7824(01)00309-2","article-title":"Case-control studies on venous thromboembolism: bias due to design? A methodological study on venous thromboembolism and steroid hormone use","volume":"65","author":"Heinemann","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2125.2002.01606.x","article-title":"Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill","volume":"53","author":"Black","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archinte.159.1.65","article-title":"Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias","volume":"159","author":"Bloemenkamp","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib44","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.0001-6349.2004.0533.x","article-title":"Pulmonary embolism associated with combined oral contraceptives: reporting incidences and potential risk factors for a fatal outcome","volume":"83","author":"Hedenmalm","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(99)01257-X","article-title":"Venous thromboembolism among new users of different oral contraceptives","volume":"354","author":"Herings","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib46","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.contraception.2006.02.002","article-title":"Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib48","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(00)02382-5","article-title":"Oral contraceptives and fatal pulmonary embolism","volume":"355","author":"Parkin","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib49","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.0001-6349.2004.00574.x","article-title":"Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users","volume":"83","author":"Samuelsson","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib50","doi-asserted-by":"crossref","first-page":"h2135","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"350","author":"Vinogradova","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib51","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00404-013-2983-9","article-title":"Risk of venous thrombosis in users of hormonal contraceptives in German gynaecological practices: a patient database analysis","volume":"289","author":"Ziller","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib52","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2151","article-title":"Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data","volume":"342","author":"Jick","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib53","doi-asserted-by":"crossref","first-page":"E1319","DOI":"10.1503\/cmaj.110463","article-title":"Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study","volume":"183","author":"Gronich","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib54","doi-asserted-by":"crossref","first-page":"d2139","DOI":"10.1136\/bmj.d2139","article-title":"Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database","volume":"342","author":"Parkin","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib55","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.contraception.2012.09.015","article-title":"Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users","volume":"87","author":"Sidney","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib56","first-page":"19","article-title":"The use of a large-scale surveillance system in Planned Parenthood Federation of America clinics to monitor cardiovascular events in users of combination oral contraceptives","volume":"44","author":"Burnhill","year":"1999","journal-title":"Int J Fertil Womens Med"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib57","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/pds.1554","article-title":"Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores","volume":"17","author":"Eng","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib58","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","article-title":"Risk of thromboembolism in women taking ethinylestradiol\/drospirenone and other oral contraceptives","volume":"110","author":"Seeger","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib59","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib60","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1783\/147118910791749416","article-title":"Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study","volume":"36","author":"Dinger","year":"2010","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib61","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.contraception.2014.01.023","article-title":"Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives","volume":"89","author":"Dinger","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib62","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/AOG.0000000000000411","article-title":"Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes","volume":"124","author":"Bergendal","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib63","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/13625187.2011.643836","article-title":"Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis","volume":"17","author":"Martinez","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib64","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1600-0412.2012.01444.x","article-title":"Hormonal contraception and venous thromboembolism","volume":"91","author":"Lidegaard","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib65","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1089\/jwh.2013.4479","article-title":"Selection of contraceptive therapy for patients with thrombophilia: a review of the evidence","volume":"23","author":"Maxwell","year":"2014","journal-title":"J Womens Health"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib66","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-200039030-00005","article-title":"Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring","volume":"39","author":"Timmer","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib67","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10","volume":"344","author":"Lidegaard","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib68","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/AOG.0b013e3182a5ec6b","article-title":"Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ring","volume":"122","author":"Dinger","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib69","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0010-7824(01)00273-6","article-title":"Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants","volume":"64","author":"Abrams","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib70","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0015-0282(01)03261-7","article-title":"Pharmacokinetic overview of Ortho Evra\/Evra","volume":"77","author":"Abrams","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib71","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"van den Heuvel","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib72","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib73","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.contraception.2006.05.071","article-title":"Cerebral venous sinus thrombosis in users of four hormonal\u00a0contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch","volume":"74","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib74","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2007.03.003","article-title":"Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol","volume":"76","author":"Jick","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib75","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2009.07.004","article-title":"Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism","volume":"81","author":"Jick","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib76","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.AOG.0000250968.82370.04","article-title":"Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users","volume":"109","author":"Cole","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib77","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.contraception.2009.12.009","article-title":"Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users","volume":"81","author":"Dore","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib78","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa1311485","article-title":"Risk of a thrombotic event after the 6-week postpartum period","volume":"370","author":"Kamel","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib79","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.ATV.19.3.700","article-title":"Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis","volume":"19","author":"Martinelli","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib80","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/107602960401000308","article-title":"Effect of age on oral contraceptive-induced venous thrombosis","volume":"10","author":"Girolami","year":"2004","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib81","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3233\/CH-2009-1190","article-title":"Yasmin and venous thromboembolism: new case reports","volume":"42","author":"Lopez","year":"2009","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib82","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.contraception.2011.06.008","article-title":"Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives","volume":"84","author":"Vaillant-Roussel","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib83","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.160.1.49","article-title":"Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects","volume":"160","author":"Bloemenkamp","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib84","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/bmj.292.6519.526","article-title":"Oral contraceptives and venous thromboembolism: findings in a large prospective study","volume":"292","author":"Vessey","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib85","doi-asserted-by":"crossref","first-page":"895","DOI":"10.7326\/0003-4819-127-10-199711150-00007","article-title":"Leiden mutation and the risks for thromboembolic disease: a clinical perspective","volume":"127","author":"Price","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib86","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1016\/j.ajog.2008.07.067","article-title":"The clinical content of preconception care: an overview and preparation of this supplement","volume":"199","author":"Jack","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib87","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/jech.52.12.775","article-title":"Combined oral contraceptives, smoking, and cardiovascular risk","volume":"52","author":"Farley","year":"1998","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib88","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(01)06522-9","article-title":"Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives","volume":"358","author":"Vasilakis-Scaramozza","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib89","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13625180008500402","article-title":"The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives","volume":"5","author":"Nightingale","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib90","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1613379","article-title":"Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use","volume":"89","author":"Abdollahi","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2016.09.027_bib91","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archinte.167.9.935","article-title":"Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom","volume":"167","author":"Huerta","year":"2007","journal-title":"Arch Intern Med"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216628479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216628479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T06:43:04Z","timestamp":1666507384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028216628479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0015028216628479"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.09.027","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined hormonal contraception and the risk of venous thromboembolism: a guideline","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a92016 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}